How Supply Chain Turbulence is Reshaping Biotech Strategy

In this episode of Denatured, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney how in light of economic uncertainty, small biotechs can turn to international harmonization standards as a stable template. U.S. tariffs are redefining competitiveness in manufacturing nations like India, China, and other parts of Asia, with China emerging as a global innovator.This episode is presented in partnership with Element Materials Technology.HostsJennifer Smith-Parker, Director of Insights, BioSpaceLori Ellis, Head of Insights, BioSpaceGuestsDr. Jihye Jang-Lee, Director of Technical Services, Element Materials TechnologyDr. Khanh Courtney, Biologics Technical Strategy Manager, Element Materials TechnologyDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

There are no comments yet.

Please log in to write the first comment.